Efficacy of rivaroxaban compared to standard of care in preventing ischemic stroke in adults with coronary or peripheral vascular disease: an integrated analysis using patient-level data
30 August 2020 (11:28 - 11:40)
Organised by:
About the speaker
Janssen R and D LLC, Spring House (United States of America)
2 More presentations in this session
Associate Professor J. Hopewell (Oxford, GB)
Doctor S. Camen (Hamburg, DE)
Access the full session
The Event
ESC Congress 2020
30 August 2020
11:28 CET
